dc.creatorGonzalez, Leticia
dc.creatorNovoa, Ulises
dc.creatorMoya, Jackeline
dc.creatorGabrielli, Luigi
dc.creatorJalil Milad, Jorge
dc.creatorGarcia, Lorena
dc.creatorChiong, Mario
dc.creatorLavandero, Sergio
dc.creatorPaz Ocaranza, Maria
dc.date.accessioned2020-01-20T19:41:07Z
dc.date.available2020-01-20T19:41:07Z
dc.date.created2020-01-20T19:41:07Z
dc.date.issued2018
dc.identifier10.1016/j.bcp.2018.08.045
dc.identifier0006-2952
dc.identifierhttps://doi.org/10.1016/j.bcp.2018.08.045
dc.identifierhttps://repositorio.uc.cl/handle/11534/27728
dc.languageen
dc.rightsacceso restringido
dc.subjectHypertension
dc.subjectInflammation
dc.subjectFibrosis
dc.subjectRenin-angiotensin system
dc.subjectAngiotensin-(1-9)
dc.subjectAT2 receptor
dc.titleAngiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension
dc.typeartículo


Este ítem pertenece a la siguiente institución